 |
Anti pan T lymphocyte monoclonal antibody |
|---|---|
| Trade Name | Anti-T Lymphocyte Immunotoxin Xmmly-H65-Rta |
| Orphan Indication | 1. For ex-vivo treatment to eliminate mature T cells from potential bone marrow grafts 2. For in-vivo treatment of bone marrow recipients to prevent graft rejection and graft versus host disease. |
| USA Market Approval | USA |
| USA Designation Date | 1986-01-29 00:00:00 |
| Sponsor | Xoma Corporation;2910 Seventh Street;Berkeley, California, 94710 |
